In this issue:
Psoriasis treatment goals with conventional systemic drugs
The Two Questions Test depression test
Incidence of psoriatic arthritis in patients with psoriasis
Time to loss of response following withdrawal of ixekizumab
Unmet needs of paediatric psoriasis patients
Factors associated with patient-reported psoriasis remission
Laser-assisted delivery of methotrexate in psoriatic nails
Safety of up to 5 years of continuous guselkumab
Long-term safety of risankizumab
Please login below to download this issue (PDF)